Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Similar documents
Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile

Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report

The Walt Disney Company - Strategy, SWOT and Corporate Finance Report

McCain Foods Limited, Inc. - Strategic SWOT Analysis Review

Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Phone: +44 (0) or BioPortfolio Limited

Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing

Compression Therapy - Medical Devices Pipeline Assessment, 2017

Critical Limb Ischemia - Pipeline Review, H1 2017

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile

Dealdoc. Acquisition agreement for Gambro. Baxter International Gambro. Dec , Wildwood Ventures Ltd. All rights reserved.

Generics Series: Authorized Generics Analysis Stemming the Generics Tide

Venture Capital Report

Digital Health Funding and M&A

Venture Capital Report

United States Sterilization Equipment Market Outlook to 2021

Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond

April By Type of Approach- Transfemoral and Transapical. By Region- North America, Europe, APAC and RoW

Mara H. Rogers, Partner Norton Rose Fulbright

2013 Global venture capital confidence survey results. How confident are investors?

Robert A. Greising Partner

State of Licensing 2011 Update

CeQur establishes Wales subsidiary

Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast,

New York Bar admission (or eligibility to obtain admission promptly) is required.

Cherry AB. Investing in a broad gaming portfolio. CEO Anders Holmgren GP Bullhound 6 December 2017

Purvi B. Maniar Member of the Firm

Master Class : Excellence in Private Equity & Deal Structuring

AMCo current. Medpace new in Sebia realised. Spire Healthcare partially realised. Healthcare. Sector insights. Our Healthcare portfolio in 2014

HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview

At the forefront of Abu Dhabi s economic diversification. August 2008

Aqua Pharmaceuticals, LLC

Transaction Services. Member of Invest Europe and SECA Swiss Priva te E quity & Corporate Finance Association

UNITED INTERNET. Business Applications Strategic Partnership with Warburg Pincus. November 8, Investor Presentation November 8, 2016

Global Paper Stationery Market Research Report 2016

Bayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE

Advised Mubadala Development Company PJSC in connection with the sale of interests in a ports operating company.

Robert A. Greising Partner

Venture Capital Report

JOHN JACK R. TUPMAN, JR CURRICULUM VITAE

How attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners

Pharma - Biotech Collaborations: Optimizing Success, Minimizing Risk and Maintaining Alignment

Wineus AG. Company presentation 2016

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3.

Omeros Raises More Than $63 Million in Financing

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships

Recent marquee transactions

Global and China Industrial Robot Industry Report, Sep. 2013

Military Robotics - Emerging Trends and Future Outlook. Reference code: DF4580PR Published: July 2015 Single user price: US$1950

Venture Capital Report

Patenting Strategies. The First Steps. Patenting Strategies / Bernhard Nussbaumer, 12/17/2009 1

KKR & Co. Inc. Goldman Sachs U.S. Financial Services Conference December 4, 2018

PitchBook. Bet ter Data. Bet ter Decisions. 4Q 2012 Private Equity. Company Inventory. Report. Sponsored by:

VentureSource China -- 1Q 2014

Clare Capital. Credentials

Chartwell Introduction and AEC Capabilities

GLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS

mergers & acquisitions all your transactions are a big deal to us

Intellectual property governance and strategic value creation:

VentureSource Europe -- 3Q 2014

Daryn A. Grossman. Proskauer.com. Partner. New York

CANADIAN PRIVATE EQUITY BUYOUT REVIEW

Global Absolute Pressure Transmitters Market Research Report 2016

Global DAW Software Market Research Report 2016

Financing Sources, Sales Pitch to Investors BARCELONA Aitana Peire Venture Valuation

Cronos Capital

PROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium

4 th Quarter Earnings Conference Call

GLOBAL PRIVATE EQUITY Report Charts

Enayat Qasimi. Partner. Experience M Street, NW Suite 450N Washington, DC Phone: Fax:

Transcription:

Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1300 321501 or Email: reportstore@bioportfolio.com 2

Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Bioton SA (Bioton) manufactures medicines and pharmaceutical preparations and produces pharmaceutical substances. Its product portfolio includes antibiotics; anesthetic drugs and eye drops; recombinant human insulin in different forms; human growth hormone and orally taken anti-diabetic medicines. The company s also provides strips for measurement of blood sugar and over-the-counter (OTC) preparations including diet supplements, products for particular nutritional uses and cosmetics for patients with certain health problems such as metabolic syndrome and diabetes. Bioton undertakes research activities in the areas of genetic engineering, biotechnology, and pharmacology and offers in-licensing services. The company operates in Europe, Asia and Australia. Bioton is headquartered in Ozarow Mazowiecki, Poland. Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of 3

the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH62082D Number of Pages : 37 Report Format : PDF Publisher Information : 4

5

Table Of Contents for Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Table of Contents Table of Contents 2List of Tables 3List of Figures 4Bioton SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5Bioton SA, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6Bioton SA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7Bioton SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8Bioton SA, Medical Devices Deals, 2010 to YTD 2016 9Bioton SA, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10Bioton SA, Pharmaceuticals & Healthcare, Deal Details 12Partnerships 12SciGen Enters into Agreement with Harbin Gloria Pharma 12Bioton Enters into Distribution Agreement with Biomm 13BIOTON Forms Joint Venture With Actavis Group 14BIOTON Enters Into Co-Development Agreement With Read-Gene 15Licensing Agreements 16SciGen Expands Its Licensing Agreement With Ferring And Bio-Technology General 16Debt Offering 17BIOTON Completes Public Offering Of Convertible Bonds For US$33 Million 17Asset Transactions 18Polpharma Acquires Antibiotics Division Of Bioton 18Acquisition 20Luraq Investments to Acquire 29.29% Stake in Indar from Mindar Holdings and Germonta Holdings for USD4.9 Million 20NovoTek Pharma Acquires 6% Stake in Bioton 21Yanming Wang Acquires 6.7% Stake in Bioton 22AIS Investment Acquires 6% Stake in Bioton 23Bimeda to Acquire Minority Interest in Bioton from Prokom Investments and Troqueera Enterprises 24Bimeda Acquires 6% Interest in Bioton from Altus Towarzystwa 25Anglo Gulf Acquires 50.01% Stake in SciGen Biopharma for USD7 Million 26SciGen Sells JV Stake In Hefei-SciGen-Bioton Biopharma For US$3.5 Million 27FDS Pharma Acquires SciGen Israel For US$2 Million 28BIOTON Acquires 50.11% Stake In Biolek For US$21 Million 29Actavis Group Plans To Acquire 51% Stake Of Biopartners Holdings From Bioton 30Sanofi-Aventis Acquires 74% Stake In BIOTON WOSTOK From Bioton 31Bioton SA - Key Competitors 33Key Employees 34Locations And Subsidiaries 35Head Office 35Other Locations & Subsidiaries 35Appendix 37Methodology 37About GlobalData 37Contact Us 37Disclaimer 37 6

List Of Tables in Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Tables Bioton SA, Pharmaceuticals & Healthcare, Key Facts, 2015 1 Bioton SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Bioton SA, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6 Bioton SA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Bioton SA, Deals By Therapy Area, 2010 to YTD 2016 8 Bioton SA, Medical Devices Deals, 2010 to YTD 2016 9 Bioton SA, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10 SciGen Enters into Agreement with Harbin Gloria Pharma 12 Bioton Enters into Distribution Agreement with Biomm 13 BIOTON Forms Joint Venture With Actavis Group 14 BIOTON Enters Into Co-Development Agreement With Read-Gene 15 SciGen Expands Its Licensing Agreement With Ferring And Bio-Technology General 16 BIOTON Completes Public Offering Of Convertible Bonds For US$33 Million 17 Polpharma Acquires Antibiotics Division Of Bioton 18 Luraq Investments to Acquire 29.29% Stake in Indar from Mindar Holdings and Germonta Holdings for USD4.9 Million 20 NovoTek Pharma Acquires 6% Stake in Bioton 21 Yanming Wang Acquires 6.7% Stake in Bioton 22 AIS Investment Acquires 6% Stake in Bioton 23 Bimeda to Acquire Minority Interest in Bioton from Prokom Investments and Troqueera Enterprises 24 Bimeda Acquires 6% Interest in Bioton from Altus Towarzystwa 25 Anglo Gulf Acquires 50.01% Stake in SciGen Biopharma for USD7 Million 26 SciGen Sells JV Stake In Hefei-SciGen-Bioton Biopharma For US$3.5 Million 27 FDS Pharma Acquires SciGen Israel For US$2 Million 28 BIOTON Acquires 50.11% Stake In Biolek For US$21 Million 29 Actavis Group Plans To Acquire 51% Stake Of Biopartners Holdings From Bioton 30 Sanofi-Aventis Acquires 74% Stake In BIOTON WOSTOK From Bioton 31 Bioton SA, Key Competitors 33 7

Bioton SA, Key Employees 34 Bioton SA, Subsidiaries 35 8

List Of Figures, Charts and Diagrams in Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Figures Bioton SA, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1 Bioton SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1 Bioton SA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1 Bioton SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1 Bioton SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Bioton SA, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6 Bioton SA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Bioton SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8 Bioton SA, Medical Devices Deals, 2010 to YTD 2016 9 9

How to Buy... Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1300 321501 We will be delighted to give you our personal attention. 10